Mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a Bm subgroup individual

Transfusion

Volumn 53, Issue 11 PART 2, 2013, Pages 2917-2927

  Nakajima, Tamiko ^b   Sano, Rie ^a   Takahashi, Yoichiro ^b   Kubo, Rieko ^b   Takahashi, Keiko ^b   Kominato, Yoshihiko ^b   Tsukada, Junichi ^b   Takeshita, Haruo ^b   Yasuda, Toshihiro ^b   Uchikawa, Makoto ^b   Isa, Kazumi ^b   Ogasawara, Kenichi ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GATA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 1; BLOOD GROUP ABO SYSTEM;

ANTIBODY SPECIFICITY; ARTICLE; BINDING SITE; BLOOD GROUP ABO SYSTEM; CELL LINEAGE; CELL STRAIN K 562; COHORT ANALYSIS; DNA RESPONSIVE ELEMENT; ERYTHROID CELL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; K562 CELL LINE;

ABO BLOOD-GROUP SYSTEM; BASE SEQUENCE; BINDING SITES; CELL LINEAGE; COHORT STUDIES; ERYTHROID CELLS; GATA1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; POINT MUTATION; RESPONSE ELEMENTS;

EID: 84893207752     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12181     Document Type: Article

References (30)

1. Schenkel-Brunner H. Human blood groups. 2nd ed. Wien, New York: Springer-Verlag; 2000.
2. Ogasawara K, Yabe R, Uchikawa M, Saitou N, Bannai M, Nakata K, Takenaka M, Fujisawa K, Ishikawa Y, Juji T, Tokunaga K. Molecular genetic analysis of variant phenotypes of the ABO blood group system. Blood 1996;88: 2732-7.
3. Yamamoto F. Molecular genetics of ABO. Vox Sang 2000;78: 91-103.
4. Chester MA, Olsson ML. The ABO blood group gene: a locus of considerable genetic diversity. Transfus Med Rev 2001;15: 177-200.
5. Ogasawara K, Yabe R, Uchikawa M, Nakata K, Watanabe J, Takahashi Y, Tokunaga K. Recombination and gene conversion-like events may contribute to ABO gene diversity causing various phenotypes. Immunogenetics 2001;53: 190-9.
6. Yu LC, Twu YC, Chou ML, Chang CY, Wu CY, Lin M. Molecular genetic analysis for the B3 allele. Blood 2002;100: 1490-2.
7. Hosseini-Maaf B, Hellberg A, Rodrigues MJ, Chester MA, Olsson ML. ABO exon and intron analysis in individuals with the AweakB phenotype reveals a novel O1v-A2 hybrid allele that causes four missense mutations in the A transferase. BMC Genet 2003;4:17.
8. Selsam A, Blasczyk R. Missense mutations outside the catalytic domain of the ABO glycosyltransferase can cause weak blood group A and B phenotypes. Transfusion 2005; 45: 1663-9.
9. Thuresson B, Hosseini-Maaf B, Hult AK, Hustinx H, Chester MA, Olsson ML. A novel Bweak hybrid allele lacks three enhancer repeats but generates normal ABO transcript levels. Vox Sang 2012;102: 55-64.
10. Hansen T, Namork E, Olsson ML, Chester MA, Heier HE. Different genotypes causing indiscernible patterns of A expression on Ael red blood cells as visualized by scanning immunogold electron microscopy. Vox Sang 1998;75: 47-51.
11. Iwasaki M, Kobayashi K, Suzuki H, Anan K. Genetic analyses for the ABO blood group subtypes in Japanese. Jpn J Transfus Med. 2000;46: 532-9.
12. Olsson ML, Thuresson B, Chester MA. An Ael allele-specific nucleotide insertion at the blood group ABO locus and its detection using a sequence-specific polymerase chain reaction. Biochem Biophys Res Commun 1995;216: 642-7.
13. Olsson ML, Irshaid NM, Hosseini-Maaf B, Hellberg A, Moulds MK, Sareneva H, Chester MA. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: identification of 15 novel A and B subgroup alleles. Blood 2001;98: 1585-93.
14. Lin M, Hou MJ, Twu YC, Yu LC. A novel A allele with 664G?A mutation identified in a family with the Am phenotype. Transfusion 2005;45: 63-9.
15. Asamura H, Ota M, Takayanagi K, Saito S, Tsukada K, Fukushima H. Molecular genetic analysis of the Am phenotype of the ABO blood group system. Vox Sang 2002;83: 263-7.
16. Sano R, Nakajima T, Takahashi K, Kubo R, Kominato Y, Tsukada J, Takeshita H, Yasuda T, Ito K, Maruhashi T, Yokohama A, Isa K, Ogasawara K, Uchikawa M. Expression of ABO blood-group genes is dependent upon an erythroid cell-specific regulatory element, which is deleted in persons with the Bm phenotype. Blood 2012;119: 5301-10.
17. Sano R, Nakajima T, Takahashi R, Kubo R, Yazawa S, Kominato Y. The 3?flanking region of the human ABO histoblood group gene is involved in negative regulation of gene expression. Legal Med 2011;13: 22-9.
18. Shima M, Nishimura T, Yoshioka A, Fukui H, Nishida S, Tsujiuchi T, Fujimura Y. The ABO blood group genotype in Japanese determined by polymerase chain reaction (PCR) using genomic DNA. Jpn J Transfus Med 1992;38: 542-7.
19. Bresnick EH, Martowicz ML, Johnson KD. Developmental control via GATA factor interplay at chromatin domains. J Cell Physiol 2005;205: 1-9.
20. Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, Kang YA, Choi K, Farnham PJ, Bresnick EH. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 2009;36: 667-81.
21. Kominato Y, Hata Y, Takizawa H, Matsumoto K, Yasui K, Tsukada J, Yamamoto F. Alternative promoter identified between a hypermethylated upstream region of repetitive elements and a CpG island in human ABO histo-blood group genes. J Biol Chem 2002;277: 37936-48.
22. Thuresson B, Chester MA, Storry JR, Olsson ML. ABO transcript levels in peripheral blood and erythropoietic culture show different allele-related patterns independent of the CBF/NF-Y enhancer motif and multiple novel allelespecific variations in the 5'- and 3'-noncoding regions. Transfusion 2008;48: 493-504.
23. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, Konkle BA. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ibb promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996;271: 22076-80.
24. Matsuda M, Sakamoto N, Fukumaki Y. Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter. Blood 1992;80: 1347-51.
25. Manco L, Ribeiro ML, Máximo V, Almeida H, Costa A, Freitas O, Barbot J, Abade A, Tamagnini G. A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency. Br J Haematol 2000;110: 993-7.
26. Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. J Clin Invest 2001;107: 753-62.
27. van Loghem JJ, Dorfmeier H, van Hart M. Two A antigens with abnormal serologic properties. Vox Sang 1957;2: 16-24.
28. Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cells A, B, H antigens is frequent in myeloid malignancies. Blood 2001;97: 3633-9.
29. Bianco-Miotto T, Hussey DJ, Day TK, O'Keefe DS, Dobrovic A. DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. Plos ONE 2009;4:e4788.
30. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, Kok CH, Gagliardi L, Friend KL, Ekert PG, Butcher CM, Brown AL, Lewis ID, To LB, Timms AE, Storek J, Moore S, Altree M, Escher R, Bardy PG, Suthers GK, D'Andrea RJ, Horwitz MS, Scott HS. GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 2011;43: 1012-17.